Results 221 to 230 of about 21,458 (231)

Botulinum toxin type A in experimental neuropathic pain

Journal of Neural Transmission, 2005
A peripheral application of botulinum toxin type A (7 U/kg) has significantly reduced thermal and mechanical hypersensitivity in rats with the partial sciatic nerve transection as a classical model of surgical neuropathy.
Zdravko Lacković, Maja Relja, Lidija Bach-Rojecky   +2 more
openaire   +4 more sources

Observations on the Type A Toxin of Clostridium botulinum

Nature, 1951
THE recent communication by Wentzel, Sterne and Polson1 makes it desirable to record some supplementary observations made in the chemical investigation of a number of toxins, especially that produced by Clostridium botulinum Type A. In the present experiments, the toxicity was determined by intraperitoneal injection into white mice of 20 gm. weight.
openaire   +3 more sources

Botulinum Toxin Type A: Evaluation of Onset and Satisfaction

Plastic Surgical Nursing, 2018
With the increasing interest in nonsurgical cosmetic procedures, this research study sought to evaluate the onset of Botulinum toxin Type A (BoNTA) between naive and non-naive consumers and its effect on satisfaction. This single-blinded research study consisted of 15 adults with scheduled appointments for neurotoxin treatment of undesired glabellar ...
Gregory Alouf, Erin Alouf, Tina Murphy
openaire   +3 more sources

Botulinum toxin type A (BOTOX) for treatment of migraine

Seminars in Cutaneous Medicine and Surgery, 2001
An open-label study and 2 double-blind, placebo-controlled studies have provided supporting evidence of botulinum toxin type A (BTX-A) as an effective, well-tolerated treatment for migraine. Observed durations of benefit were consistent with known properties of BTX-A.
Mitchell F. Brin, Andrew Blitzer, Janice M. Pogoda, William J. Binder   +3 more
openaire   +5 more sources

Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A

Movement Disorders, 1993
AbstractFifteen patients with torticollis who had been treated with repeated injections of botulinum toxin type A (botox A) developed antibodies to the toxin. This resulted in loss of benefit in the 13 patients who had improved with botox A injections and failure to develop muscle atrophy after injection in all 15 patients.
Stanley Fahn, Paul E. Greene
openaire   +3 more sources

Botulinum toxin type A

Journal of the American Academy of Dermatology, 2005
Alastair Carruthers, Jean Carruthers
openaire   +3 more sources

The cosmetic uses of Botulinum toxin type A

International Journal of Dermatology, 1999
Anthony V. Benedetto, . Do
openaire   +3 more sources

Botulinum Toxin Type A

2012
Stephen M. Stahl, Howard S. Smith, Marco Pappagallo   +2 more
openaire   +2 more sources

Availability of botulinum toxin type A

International Journal of Dermatology, 1999
openaire   +2 more sources

Worldwide experience with botulinum toxin type A

Journal of Cosmetic and Laser Therapy, 2003
openaire   +3 more sources